Pony Testing International Group Co (300887) - Net Assets
Based on the latest financial reports, Pony Testing International Group Co (300887) has net assets worth CN¥2.90 Billion CNY (≈ $424.41 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.49 Billion ≈ $511.21 Million USD) and total liabilities (CN¥593.17 Million ≈ $86.80 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Pony Testing International Group Co liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.90 Billion |
| % of Total Assets | 83.02% |
| Annual Growth Rate | 24.19% |
| 5-Year Change | 69.26% |
| 10-Year Change | N/A |
| Growth Volatility | 37.55 |
Pony Testing International Group Co - Net Assets Trend (2016–2024)
This chart illustrates how Pony Testing International Group Co's net assets have evolved over time, based on quarterly financial data. Also explore Pony Testing International Group Co total assets for the complete picture of this company's asset base.
Annual Net Assets for Pony Testing International Group Co (2016–2024)
The table below shows the annual net assets of Pony Testing International Group Co from 2016 to 2024. For live valuation and market cap data, see Pony Testing International Group Co stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.08 Billion ≈ $450.91 Million |
-11.13% |
| 2023-12-31 | CN¥3.47 Billion ≈ $507.39 Million |
-2.36% |
| 2022-12-31 | CN¥3.55 Billion ≈ $519.66 Million |
+75.80% |
| 2021-12-31 | CN¥2.02 Billion ≈ $295.59 Million |
+10.95% |
| 2020-12-31 | CN¥1.82 Billion ≈ $266.41 Million |
+104.95% |
| 2019-12-31 | CN¥888.30 Million ≈ $129.99 Million |
+14.86% |
| 2018-12-31 | CN¥773.41 Million ≈ $113.17 Million |
+20.97% |
| 2017-12-31 | CN¥639.33 Million ≈ $93.55 Million |
+17.42% |
| 2016-12-31 | CN¥544.47 Million ≈ $79.67 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Pony Testing International Group Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 83.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥892.88 Million | 29.10% |
| Other Components | CN¥2.18 Billion | 70.90% |
| Total Equity | CN¥3.07 Billion | 100.00% |
Pony Testing International Group Co Competitors by Market Cap
The table below lists competitors of Pony Testing International Group Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mavi Giyim Sanayi Ve Ticaret AS
IS:MAVI
|
$770.88 Million |
|
Rashtriya Chemicals and Fertilizers Limited
NSE:RCF
|
$770.91 Million |
|
Metals X Limited
F:FG5
|
$771.33 Million |
|
SK Networks Co Ltd
KO:001740
|
$771.52 Million |
|
Diversified United Investment Ltd
AU:DUI
|
$770.60 Million |
|
Zhejiang Dafeng Industrial Co Ltd
SHG:603081
|
$770.34 Million |
|
Sawit Sumbermas Sarana Tbk
JK:SSMS
|
$770.22 Million |
|
Hangzhou Minsheng Healthcare Co Ltd
SHE:301507
|
$770.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pony Testing International Group Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,455,605,020 to 3,068,574,853, a change of -387,030,167 (-11.2%).
- Net loss of 356,312,970 reduced equity.
- Dividend payments of 39,050,620 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-356.31 Million | -11.61% |
| Dividends Paid | CN¥39.05 Million | -1.27% |
| Other Changes | CN¥8.33 Million | +0.27% |
| Total Change | CN¥- | -11.20% |
Book Value vs Market Value Analysis
This analysis compares Pony Testing International Group Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.72x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.55x to 1.72x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥6.23 | CN¥9.65 | x |
| 2018-12-31 | CN¥7.54 | CN¥9.65 | x |
| 2019-12-31 | CN¥8.66 | CN¥9.65 | x |
| 2020-12-31 | CN¥13.31 | CN¥9.65 | x |
| 2021-12-31 | CN¥14.74 | CN¥9.65 | x |
| 2022-12-31 | CN¥12.33 | CN¥9.65 | x |
| 2023-12-31 | CN¥6.33 | CN¥9.65 | x |
| 2024-12-31 | CN¥5.62 | CN¥9.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pony Testing International Group Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -11.61%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -23.12%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.25x
- Recent ROE (-11.61%) is below the historical average (9.48%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 18.39% | 12.25% | 1.09x | 1.38x | CN¥45.66 Million |
| 2017 | 15.75% | 9.69% | 1.11x | 1.46x | CN¥36.79 Million |
| 2018 | 16.60% | 10.27% | 1.12x | 1.44x | CN¥51.08 Million |
| 2019 | 14.08% | 9.72% | 0.98x | 1.48x | CN¥36.24 Million |
| 2020 | 8.99% | 11.48% | 0.67x | 1.16x | CN¥-18.33 Million |
| 2021 | 10.91% | 10.98% | 0.72x | 1.38x | CN¥18.29 Million |
| 2022 | 9.07% | 8.53% | 0.82x | 1.29x | CN¥-33.06 Million |
| 2023 | 3.12% | 4.37% | 0.57x | 1.26x | CN¥-237.78 Million |
| 2024 | -11.61% | -23.12% | 0.40x | 1.25x | CN¥-663.17 Million |
Industry Comparison
This section compares Pony Testing International Group Co's net assets metrics with peer companies in the Specialty Business Services industry.
Industry Context
- Industry: Specialty Business Services
- Average net assets among peers: $1,919,627,192
- Average return on equity (ROE) among peers: 2.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pony Testing International Group Co (300887) | CN¥2.90 Billion | 18.39% | 0.20x | $770.63 Million |
| Shaanxi Jinye Science Technology and Education Group Co Ltd (000812) | $1.02 Billion | 7.08% | 0.49x | $461.18 Million |
| Tungkong Inc (002117) | $612.06 Million | 12.09% | 0.62x | $781.70 Million |
| Eternal Asia Supply Chain Management Ltd (002183) | $10.31 Billion | 4.91% | 3.20x | $2.12 Billion |
| Hongbo Co Ltd (002229) | $1.34 Billion | -21.81% | 1.32x | $1.19 Billion |
| Beijing Shengtong Printing Co Ltd (002599) | $1.54 Billion | 6.01% | 0.53x | $533.94 Million |
| Shanghai Nar Industrial Co Ltd (002825) | $621.54 Million | 9.97% | 0.35x | $499.27 Million |
| Xuchang Ketop Testing Research Ins (003008) | $1.00 Billion | 7.40% | 0.05x | $357.63 Million |
| Suzhou Electrical Apparatus Sci (300215) | $260.89 Million | 23.37% | 2.29x | $938.31 Million |
| Trust Alliance Information Development Inc Ltd Shanghai (300469) | $294.38 Million | -21.69% | 2.51x | $2.17 Billion |
| Hunan Huakai Cultural and Creative Co Ltd (300592) | $2.19 Billion | -3.99% | 0.36x | $769.81 Million |
About Pony Testing International Group Co
Pony Testing Co., Ltd. provides testing, measurement, calibration, inspection, evaluation, factory inspection, and other professional one-stop technical solutions in China. The company offers biopharmaceutical CRO/CDMO and drug testing services; medical device testing; medical testing/pathological diagnosis; toxicology and pathology experiments; food/liquor/beverage testing; agricultural product … Read more